Health Condition 1: O140- Mild to moderate pre-eclampsia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with pre-eclampsia above 20 weeks of gestation Those who are willing to participate in the study
Exclusion criteria
Exclusion criteria: Patients with pre-eclampsia above 20 weeks of gestation with altered sensorium , Patients who are getting the loading dose of magnesium sulphate from other hospitals
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Level of Pain at the injection site ,Drug leakage, Post Injection Gluteal Inflammation, Occurrence of SeizureTimepoint: During the prophylactic treatment-24 hours | — |
Secondary
| Measure | Time frame |
|---|---|
| Level of Pain at the injection site ,Drug leakage, Post Injection Gluteal Inflammation, Occurrence of SeizureTimepoint: During the period of prophylactic treatment-24 hours | — |
Countries
India
Contacts
National Institute of nursing Education